Global Type 2 Diabetes Mellitus Treatment Market Size & Outlook
The global type 2 diabetes mellitus treatment market size was estimated at USD 57,467.4 million in 2023 and is projected to reach USD 91,966.5 million by 2030, growing at a CAGR of 6.9% from 2024 to 2030.
Revenue, 2023 (US$M)
$57,467.4
Forecast, 2030 (US$M)
$91,966.5
CAGR, 2024 - 2030
6.9%
Report Coverage
Worldwide
Global type 2 diabetes mellitus treatment market, 2018-2030 (US$M)
Related Markets
Global type 2 diabetes mellitus treatment market highlights
- The global type 2 diabetes mellitus treatment market generated a revenue of USD 57,467.4 million in 2023 and is expected to reach USD 91,966.5 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 6.9% by 2030.
- In terms of segment, insulin accounted for a revenue of USD 57,467.4 million in 2023.
- Insulin is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
Global data book summary
| Market revenue in 2023 | USD 57,467.4 million |
| Market revenue in 2030 | USD 91,966.5 million |
| Growth rate | 6.9% (CAGR from 2024 to 2030) |
| Largest segment | Insulin |
| Fastest growing segment | Insulin |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin |
Other key industry trends
- In terms of revenue, the North America accounted for 39.5% of the global type 2 diabetes mellitus treatment market in 2023.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Type 2 diabetes mellitus treatment market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Daiichi Sankyo Co Ltd | View profile | 17435 | 3-5-1, Nihonbashi-honcho, Chuo-ku, Tokyo, Japan, 103-8426 | https://www.daiichisankyo.com |
| Takeda Pharmaceutical Co Ltd | View profile | 49095 | 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, Japan, 103-8668 | https://www.takeda.com |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
Global type 2 diabetes mellitus treatment market size, by regions, 2018-2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
